TTMI Form 144 Discloses RSU Vesting and Proposed 5,761-Share Sale
Rhea-AI Filing Summary
TTM Technologies (TTMI) filed a Form 144 reporting a proposed sale of 5,761 common shares valued at $235,394.36 to be sold through Merrill Lynch on 08/22/2025 on NASDAQ. The filing states these shares were acquired as restricted stock unit vesting on 08/22/2025 (amount recorded as 10,702 units) and that payment was not applicable. The filer also disclosed a prior sale by Daniel L. Boehle of 6,260 common shares on 06/23/2025 for gross proceeds of $227,881.08. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider notice showing RSU vesting and planned small-scale sale; complies with Rule 144 disclosure requirements.
This Form 144 documents a planned sale of 5,761 common shares via Merrill Lynch with an aggregate market value of $235,394.36 and records the acquisition source as RSU vesting on the same date as the planned sale. The filing also reports a prior insider sale of 6,260 shares for $227,881.08. From a compliance perspective, the submission contains the necessary items: class of securities, broker, amounts, acquisition details and the seller’s representation about material nonpublic information. The amounts involved are modest relative to the issuer's reported outstanding shares of 103,313,274, suggesting limited market impact. No indications of trading-plan adoption date or additional restrictions are provided in the filing.
TL;DR: Disclosure appears complete for a Form 144; insider sales are disclosed but not evidently material to shareholders.
The document shows the insider relied on standard Rule 144 procedures to notify of an intended sale and discloses a recent sale within the prior three months. Key governance elements—transaction dates, broker, source of shares (RSU vesting), and a representation regarding material information—are present. The filing does not state a 10b5-1 plan adoption date, so no affirmative trading-plan defense is asserted. Given the small transaction sizes versus total shares outstanding, the filing is more notable for transparency than for indicating material shift in insider conviction.